A Science-ish Q&A: Dr. Ben Goldacre
| Q: Your focus has shifted over the years-from the low-hanging fruit of alternative medicine to the more intricate and complex dealings of pharmaceutical companies. Why the change? A: I think the trajectory is probably from easy aspects of research … See all stories on this topic » |
 Macleans.ca |
